dexcom g6 products

Dexcom G6 CGM System for personal use

Dexcom G6 is the first real-time, integrated Continuous Glucose Monitoring System (iCGM) that is authorized to work interoperably with a range of connected insulin pens and hybrid closed-loop system partners.^†  It features a 10-day sensor and requires zero fingersticks^‡  or scanning, supporting greater freedom and flexibility in diabetes management for patients ages 2 years and older. Dexcom G6 is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range,^1,2,10-12  leading to better quality of life.³ The Dexcom G6 app is available in English and Spanish on compatible smart devices.*

^‡If your glucose alerts and readings from Dexcom G6 CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

discover why Dexcom G6 is the

#1 PREFERRED CGM BY HEALTHCARE PROFESSIONALS⁴ & PATIENTS⁵

#1 claims

powerful. proven. protective.

Dexcom G6 can help empower your patients with proven accuracy⁸ and a suite of protective alerts, including the Urgent Low Soon alert. Whether they have type 1 or type 2 diabetes (T1D/T2D), Dexcom G6 can help simplify how you treat your patients—in-person or via telehealth—to maximize their care.

Available in English and Spanish

You can prescribe to your English- and Spanish-speaking patients with confidence knowing that they can use this powerful tool in their spoken language.

Accuracy and outcomes

Dexcom CGM use is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.^2,3,10-12

Real-time continuous glucose monitoring (RT-CGM)

Real-time glucose readings are sent straight to your patient's smart device* or receiver whenever, wherever.

Remote monitoring

Your patients can choose to share their glucose data with up to 10 Followers.^#If patients give them the ability to receive alert notifications, Followers can help patients stay in range.

Indicated for 2 years and older

Dexcom is the only provider of CGM systems indicated for children ages 2 years and older, and Dexcom G6 extends the benefits of remote monitoring to the same patient age range.^#

Dexcom Clarity compatibility

Use of the Dexcom Clarity software and reports can facilitate better conversations about a patient’s Dexcom G6 glucose data during telehealth or in-person visits.

Urgent Low Soon alert

The Urgent Low Soon alert can warn patients in advance of potentially dangerous low glucose values (55 mg/dL or below) and is associated with reduced hypoglycemia, without a corresponding increase in hyperglycemia.^‡‡,9

the world's most powerful iCGM System

Learn more about how Dexcom G6 can support your patients with T1D or insulin-treated T2D. Watch the video below for guidance that can help your patients as they learn to use Dexcom G6 to better manage their diabetes in real time.

Getting Started Video

Dexcom G6 CGM System components

Using the auto-applicator, patients or caregivers can insert the sensor and then snap in the transmitter. Once the system completes warm-up they will be able to view real-time glucose data from the transmitter via a patient's selected display device.*

applicator

Auto-Applicator

Provides simple sensor insertion at the push of a button. A patient can apply the sensor on their own by following the instructions for use.

sensor

Sensor

Monitors interstitial glucose levels through a small wire inserted just underneath the skin, sending a signal to the transmitter (10-day lifespan).

transmitter

Transmitter

Fastened on top of the sensor; sends data wirelessly to the wearer's compatible display device* (3-month lifespan).

display device

Display Device

Allows patients to view their real-time glucose data and trends. Dexcom G6 also enables patients to receive a suite of alerts, an Urgent Low alarm, and other notifications on their display device*, which can help warn them of high or low glucose levels.

^*Smart devices sold separately.

why prescribe the Dexcom G6?

Dexcom G6 removes the burden of having to fingerstick or scan for your patients to receive real-time glucose readings.

^‡If your glucose alerts and readings from Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Dexcom G6 CGM Trend Graph

Representative in-clinic session data shows how calibrations can result in improved, worsening, or no effects on the accuracy of the Dexcom G6 CGM System. It supports the notion that overall, the absence of calibrations does not impact the ability of Dexcom G6 to provide accurate glucose readings.⁵

Calibration

Patients show sustained glycemic benefit with long-term real-time CGM (rtCGM) use.^#,6 Dexcom rtCGM use is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.^2,3

COMISAIR chart

SEE NIH.GOV CLINICAL EVIDENCE

The Dexcom G6 sensor prevents clinically significant interference from acetaminophen, and readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000 mg every 6 hours.*

*Taking a higher does than 1,000 mg every 6 hours may affect Dexcom G6 readings.

Acetaminophen

Featured Resources

View all resources

DIaMonD - A Randomized Controlled Trial Examining the Benefit of CGM Use for Adults with Type 1 Diabetes on Insulin Injections

DIaMonD Study 1 shows that Dexcom CGM use improves glucose control in adults with type 1 diabetes using insulin injections.

Clinical Studies

Prescribing Info

How to Fill a Dexcom G6 Pharmacy Prescription

Filling a Dexcom G6 Continuous Glucose Monitor prescription is easy and quick. Dexcom CGM diabetic supplies are available via next-business-day delivery through a pharmacy wholesaler. Filling an RX...

Prescribing Info

View all resources

savings center

your patients can save over 50% on Dexcom G6^§§

Dexcom G6 has never been more accessible and affordable, even for those without CGM coverage. With our pharmacy savings program, your patients can get a coupon to save on the monthly cash price of their Dexcom supplies.

Visit Dexcom Savings Center

*Smart devices sold separately. For a list of compatible devices, visit dexcom.com/compatibility.

^†To learn more about insulin pump integrations and compatibility with Dexcom G6, visit dexcom.com/g6/integrations-and-compatibility.

^§Refers to estimated out-of-pocket cost for eligible commercially insured patients from the Dexcom G6 sensor when claims are adjudicated as a pharmacy benefit, and includes benefits and offerings through available Dexcom programs, such as the voucher program. Actual cost may vary and is subject to individual insurance coverage.

^||Comparison of NPS scores of Dexcom, Abbott, and Medtronic, Seagrove Survey 2021 Patient Perspectives.

^¶MARD is a statistical measure of accuracy.

^#Separate Dexcom Follow app required. Internet connectivity required for data sharing. Followers should always confirm readings on the Dexcom G6 app or receiver before making treatment decisions. Followers must have compatible smart devices to use the Dexcom Follow app.

**Patient must first sync their Dexcom G6 data with the Dexcom Clarity app and consent to share their data with their healthcare provider. An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility.

^‡‡This predictive alert can be triggered with impending hypoglycemia (glucose of 55 mg/dL or below is predicted to occur within the next 20 minutes).

^§§Savings based on $200 off retail cash price of monthly sensor pack and $200 off transmitter over 3-month period.

¹ Beck RW, et al. JAMA. 2017;317(4):371-378.

² Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.

³ Dexcom, data on file, 2022.

⁴ Seagrove HCP Survey Q121, p65.

⁵ dQ&A US Q1 2021 Diabetes Connections Patient Panel Report. 2021;69-72.

⁶ IQVIA, February 2022.

⁷ Managed Markets Insights & Technology, LLC. MMIT Analytics, June 2022.

⁸ Shah VN, et al. Diabetes Technol Ther. 2018;20(6):428-433. 

⁹ Puhr S, et al. Diabetes Technol Ther. 2019;21(4):155-8.

¹⁰ Martens T, et al. JAMA. 2021;325(22):2262-2272.

¹¹ Laffel LM, et al. JAMA. 2020;323(23):2388-2396.

¹² Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider’s NPI

Please provide Facility/Office address Only- We will not ship to home address

Is your patient on a connected pump device?

Yes

No

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.